Jumat, 03 Februari 2012

5th ISCR Annual Conference receives overwhelming response from industry

Dr Prem Kumar Reddy inaugurating the conference

The fifth annual conference of Indian Society for Clinical Research (ISCR) was recently held at Taj Krishna in Hyderabad. The theme for this year's conference was ‘Beyond Efficiency to Excellence’ and was attended by over 400 delegates from India and abroad.
Dr Prem Kumar Reddy, a leading authority on cancer research, inaugurated the conference and delivered the keynote address. This was followed by a welcome address by Dr Krathish Bopanna, President, ISCR. Bindhya Cariappa, Chairperson, Scientific Committee presented an overview of the conference, which was followed by a vote of thanks by Dr Radhika Bobba, Chairperson, Local Organising Committee. 
A panel discussion in progress

In synchrony to ISCR's objective of ensuring that the conference serves as a platform for the best minds in clinical research to share innovative views and best practices in clinical research, this year’s sessions focussed on excellence in line with the conference theme. The two-day conference had two clinical research tracks that touched upon each aspect of clinical development and covered early development, regulatory affairs, medical writing, clinical research technology, ethics, investigator site perspectives, project management, data management, quality assurance, pharmacovigilance, biostatistics and a discussion on the perception of clinical trials in India.  
Delegates attended Akshaya, Mandar Kelkar,
 Dr.Parthasarathi, Anand Harugery
The conference was preceded by four workshops on study management, medical writing, statistics and pharmacovigilance. Unique to this conference was also the young clinical research debate conducted at the end of day one of the conference. The conference was concluded by a valedictory speech by Dr PM Bhargava, scientist and recipient of Padma Bhushan and a vote of thanks to delegates, speakers, sponsors, organisers and volunteers. 
Participants at the conference
Speakers who attended the conference were Dr Rajesh Karan, Novartis; Dr Julius Vaz, Dr Reddy's Laboratories; Dr Shreemanta K Parida, Dept of Biotechnology; Dr Deven Parmar, Wockhardt; Dr Sudhakar Mairpadi, Phillips; Shenaz Vakharia, Theraverity; Dr Shashidhar Rao, Novartis; Dr Sanjay A Pai, Columbia Asia; Dr Roopa, Basrur, Parexel; Dr Graham Bunn, Medidata Solutions; Gunjan Jain, Oracle; Dr SD Rajendran, Sristek; Dr Ajay Parker, SIRO Clinpharm; Carol Isaacson Barash, Genetics, Ethics and Policy Consulting; Dr Gauri Gholap, Optra Systems; Sudip Sinha, CliniRx; Dr Mubarak Naqvi, Sanofi Aventis; Dr Aamir Shaikh, Assansa; Dr Ajoy Roy, Parexel; Dhiren Joshi, Voisin Life Sciences; Vivek Ahuja, Baxter; Dr Manish Kumar Shah, Pfizer; Narasimha Kumar, Parexel; Dr Sneha Limaye, CRF; Dr Milind Antani, Nishith Desai Associates; Gourav Kumar, Apollo Hospitals; Dr Vishwanath Iyer, Novartis; Dr Chitra Lele, Sciformix; Tommy Pedersen, Quintiles; Bindhya Cariappa, ClinTec international; Dr Rupam, KIMS; PV Rao, eminent media person; Dr Suresh Menon, Novartis; Professor Sarma, NALSAR; Dr Nimita Limaye, Siro Clinpharm; Dr Hema Bajaj, Sanofi Aventis; Mark Aubrey, Daiichi Sankyo; Dr Raghunatha Rao, NIMS; Dr Purvish Parikh, Americares and Dr Senthil Rajappa, Indo-American Cancer Hospital. The resounding success of the conference has raised the bar for the sixth annual conference to be held in Mumbai next year.
Source:ExpressPharma
by
Akshaya Srikanth
Pharm.D Intern

Tidak ada komentar:

Posting Komentar